Miami, FL — November 26, 2025 — Leads & Copy — Nuvation Bio Inc. (NYSE: NUVB) executives will participate in fireside chats at two upcoming investor conferences. David Hung, M.D., Founder, President, and Chief Executive Officer, and Philippe Sauvage, Chief Financial Officer, will represent Nuvation Bio at the events.
The conferences are the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 9:35 a.m. ET and the Citi 2025 Global Healthcare Conference on Wednesday, December 3, 2025, at 9:00 a.m. ET. Both conferences will take place in Miami, FL.
Live webcasts of the fireside chats will be available in the Investor Relations section of Nuvation Bio’s website. Archived recordings will be accessible for 90 days following each event.
Nuvation Bio is a global oncology company focused on developing therapies that create a positive impact on patients’ lives. The company’s pipeline includes taletrectinib (IBTROZI™), a next-generation ROS1 inhibitor; safusidenib, a brain-penetrant IDH1 inhibitor; NUV-868, a BD2-selective BET inhibitor; and an innovative drug-drug conjugate (DDC) program.
Nuvation Bio was founded in 2018 by David Hung, M.D., a biopharma industry veteran who previously founded Medivation, Inc.
Nuvation Bio has offices in New York, San Francisco, Boston, and Shanghai.
Contact:
Nuvation Bio Inc.
Source: Nuvation Bio Inc.
